LeadIQ logo
Learn more at LeadIQ.com
✕

Access Insights for Supernus Pharmaceuticals, Inc. and Millions of Other Companies

Sign up for full access to Supernus Pharmaceuticals, Inc. information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Insights

Expansion through partnerships Supernus Pharmaceuticals, Inc. recently partnered with M8 Pharmaceuticals for an exclusive licensing agreement in Latin America, presenting a potential sales opportunity for expanding market reach and increasing revenue streams through this strategic collaboration.

Investor interest and funding Wellington Management Co, Trust Point Inc., and Envestnet | Retirement Solutions have made substantial investments into Supernus Pharmaceuticals, Inc., indicating investor confidence in the company's growth potential. Leveraging this investor interest can lead to increased financial stability and potential for further expansion.

Product development for market needs Supernus Pharmaceuticals, Inc. is actively developing new product candidates to address unmet needs in the CNS market such as ADHD in adults, treatment-resistant depression, and epilepsy. Identifying market trends and aligning product development efforts with customer needs can position the company for successful product launches and increased sales opportunities.

Regulatory updates driving sales The regulatory update for SPN-830, an investigational apomorphine infusion device for Parkinson's disease, presents a significant sales opportunity for Supernus Pharmaceuticals, Inc. Timely FDA approvals and successful product launches can boost sales revenue and market share within the targeted segment.

Strategic focus on emerging markets With a focus on developing products for the treatment of central nervous system diseases, Supernus Pharmaceuticals, Inc. is strategically targeting emerging markets with a high demand for CNS therapeutics. Identifying and capitalizing on growth opportunities in these markets can drive sales growth and establish a strong market presence for the company.

Similar companies to Supernus Pharmaceuticals, Inc.

✕

Access Insights for Supernus Pharmaceuticals, Inc. and Millions of Other Companies

Sign up for full access to Supernus Pharmaceuticals, Inc. information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Supernus Pharmaceuticals, Inc. Tech Stack

Supernus Pharmaceuticals, Inc. uses 8 technology products and services including SAP, Microsoft 365, Lightbox, and more. Explore Supernus Pharmaceuticals, Inc.'s tech stack below.

  • SAP
    Customer Relationship Management
  • Microsoft 365
    Email
  • Lightbox
    Javascript Libraries
  • Cisco
    Network Hardware
  • Amazon Web Services
    Platform As A Service
  • Microsoft Defender
    Security
  • Drupal Multisite
    Web Hosting
  • Nginx
    Web Servers

Media & News

Supernus Pharmaceuticals, Inc.'s Email Address Formats

Supernus Pharmaceuticals, Inc. uses at least 1 format(s):
Supernus Pharmaceuticals, Inc. Email FormatsExamplePercentage
FLast@supernus.comJDoe@supernus.com
75%
First_Last@supernus.comJohn_Doe@supernus.com
17%
First.Last@supernus.comJohn.Doe@supernus.com
5%
Last@supernus.comDoe@supernus.com
3%

Frequently Asked Questions

Where is Supernus Pharmaceuticals, Inc.'s headquarters located?

Minus sign iconPlus sign iconSupernus Pharmaceuticals, Inc.'s main headquarters is located at 9715 Key West Ave Rockville, Maryland 20850 US. The company has employees across 3 continents, including North AmericaAsiaAfrica.

What is Supernus Pharmaceuticals, Inc.'s phone number?

Minus sign iconPlus sign icon You can contact Supernus Pharmaceuticals, Inc.'s main corporate office by phone at
✕

Access Insights for Supernus Pharmaceuticals, Inc. and Millions of Other Companies

Sign up for full access to Supernus Pharmaceuticals, Inc. information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+1-301-838-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Supernus Pharmaceuticals, Inc.'s stock symbol?

Minus sign iconPlus sign iconSupernus Pharmaceuticals, Inc. is a publicly traded company; the company's stock symbol is SUPN.

What is Supernus Pharmaceuticals, Inc.'s official website and social media links?

Minus sign iconPlus sign iconSupernus Pharmaceuticals, Inc.'s official website is supernus.com and has social profiles on LinkedIn.

How much revenue does Supernus Pharmaceuticals, Inc. generate?

Minus sign iconPlus sign icon As of September 2024, Supernus Pharmaceuticals, Inc.'s annual revenue reached $75M.

What is Supernus Pharmaceuticals, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign iconSupernus Pharmaceuticals, Inc.'s SIC code is 2834 - Pharmaceutical Preparations NAICS code is 446110 - Pharmacies and Drug Stores.

How many employees does Supernus Pharmaceuticals, Inc. have currently?

Minus sign iconPlus sign iconAs of September 2024, Supernus Pharmaceuticals, Inc. has approximately 713 employees across 3 continents, including North AmericaAsiaAfrica. Key team members include Chief Medical Officer: J. R.Chief Scientific Officer & Svp, Intellectual Property: P. P. B.Vice President Of Sales - Parkinson’s: D. C.. Explore Supernus Pharmaceuticals, Inc.'s employee directory with LeadIQ.

What industry does Supernus Pharmaceuticals, Inc. belong to?

Minus sign iconPlus sign iconSupernus Pharmaceuticals, Inc. operates in the Pharmaceutical Manufacturing industry.

What technology does Supernus Pharmaceuticals, Inc. use?

Minus sign iconPlus sign iconSupernus Pharmaceuticals, Inc.'s tech stack includes SAPMicrosoft 365LightboxCiscoAmazon Web ServicesMicrosoft DefenderDrupal MultisiteNginx.

What is Supernus Pharmaceuticals, Inc.'s email format?

Minus sign iconPlus sign iconSupernus Pharmaceuticals, Inc.'s email format typically follows the pattern of . Find more Supernus Pharmaceuticals, Inc. email formats with LeadIQ.

When was Supernus Pharmaceuticals, Inc. founded?

Minus sign iconPlus sign iconSupernus Pharmaceuticals, Inc. was founded in 2005.
Supernus Pharmaceuticals, Inc.

Supernus Pharmaceuticals, Inc.

Pharmaceutical ManufacturingMaryland, United States501-1000 Employees

We are a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases. Our extensive expertise in product development has been built over the past 30 years: initially as a standalone development organization, then as a U.S. subsidiary of Shire plc and, in late 2005, as Supernus Pharmaceuticals Inc. We market our products in the United States through our own specialty sales force and seek strategic collaborations with other pharmaceutical companies to license our products outside the United States.

We market Qelbree® (viloxazine extended-release) for the treatment of attention deficit/hyperactivity disorder (ADHD) in children ages 6 to 17. Trokendi XR® (extended-release topiramate) for the prophylaxis of migraine and the treatment of epilepsy, Oxtellar XR® (extended-release oxcarbazepine) for the treatment of epilepsy, Apokyn® (apomorphine hydrochloride injection) for the acute treatment of hypomobility in advanced Parkinson’s disease (PD), Myobloc® (rimabotulinumtoxinB) for the treatment of cervical dystonia and treatment of chronic sialorrhea in adults, and Xadago® (safinamide) as an adjunctive treatment to levodopa/carbidopa in PD patients with hypomobility.

We are also developing several product candidates to address large market opportunities in the CNS market, including SPN-812 for the treatment of ADHD in adults, apomorphine infusion pump for hypomobility in PD, SPN-820 (NV-5138) for treatment-resistant depression, and SPN-817 for the treatment of epilepsy.

✕

Access Insights for Supernus Pharmaceuticals, Inc. and Millions of Other Companies

Sign up for full access to Supernus Pharmaceuticals, Inc. information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Section iconCompany Overview

Headquarters
9715 Key West Ave Rockville, Maryland 20850 US
Phone number
✕

Access Insights for Supernus Pharmaceuticals, Inc. and Millions of Other Companies

Sign up for full access to Supernus Pharmaceuticals, Inc. information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+1-301-838-****
Website
supernus.com
SIC Code
2834 - Pharmaceutical Preparations
Stock Symbol
SUPN
NAICS Code
446110 - Pharmacies and Drug Stores
Founded
2005
Employees
501-1000

Section iconMedia & News

Section iconFunding & Financials

  • $50M$100M

    Supernus Pharmaceuticals, Inc.'s revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $50M$100M

    Supernus Pharmaceuticals, Inc.'s revenue is in the range of $50M$100M

Company Leadership

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

✕

Access Insights for Supernus Pharmaceuticals, Inc. and Millions of Other Companies

Sign up for full access to Supernus Pharmaceuticals, Inc. information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.